TMCnet News
Matthew O'Brien Joins Piper Jaffray Medical Technology Investment Research TeamPiper Jaffray (NYSE:PJC) is pleased to announce the hiring of Matthew O'Brien as a principal and senior research analyst. O'Brien will be based in the firm's Chicago office, focused on the orthopaedics and spine space as part of the medical technology equity research team. "Piper Jaffray has a longstanding reputation in the medical technology arena," said Michael Cox, director of equity research at Piper Jaffray. "Our medtech leadership reflects an ongoing commitment to providing relevant and timely insights to clients. Matt will be integral in contributing to this effort." Previously, O'Brien spent 10 years at William Blair & Company, LLC, where he was most recently a senior analyst leading coverage of orthopaedics, vision care and heart failure companies. Prior to that, he worked in investment banking and financial advisory at Duff & Phelps, LLC. O'Brien holds a bachelor's degree in finance from DePaul University and a Master of Business Adinistration degree from the University of Chicago. Piper Jaffray has a total of 29 senior research analysts located in Minneapolis, New York, San Francisco and Chicago. The firm provides coverage on approximately 584 companies in the following key sectors: business & financial services; clean technology & industrial growth; consumer; healthcare; and technology, media & telecommunications.
About Piper Jaffray * License pending Follow Piper Jaffray: LinkedIn | Facebook | Twitter © 2014 Piper Jaffray Companies, 800 Nicollet Mall, Suite 1000, Minneapolis, Minnesota 55402-7020
|